Editor’s note: This is one of five profiles of the finalists for Startup CEO of the Year ahead of the 2023 GeekWire Awards. Read the others on Humanly CEO Prem Kumar, Rebellyous Foods CEO… Read More
Healthcare company 98point6 landed additional investment to support its transition to a licensor of virtual care solutions, following a move to offload parts of its business. The fresh funding comes after… Read More
Seattle digital health nonprofit Audere will advance its technology to improve the accuracy of rapid diagnostic tests with $9.35 million in fresh funding from the Bill & Melinda Gates Foundation.… Read More
Washington state lawmakers finalized passage of a bill Monday that provides privacy protections for consumer health data. The bill protects health data collected by consumer apps and websites, which is… Read More
Seagen fielded multiple offers before agreeing to a whopping $43 billion acquisition by pharma giant Pfizer. The Seattle-area company revealed negotiation details with several companies in a recent SEC filing… Read More
Healthcare data holds great potential to improve medicine, but mining it is not easy. To get to the gold, Truveta built a large AI-powered model to crunch through medical texts… Read More
Vancouver, B.C.-based biotech company Aspect Biosystems inked a partnership worth potentially more than $2.6 billion with Danish biopharma giant Novo Nordisk to develop “bioprinted” tissue therapeutics. The deal comes with… Read More
— Mark Adams is stepping down as chief operating officer of Adaptive Biotechnologies, the company said today in a regulatory filing. Adams joined the Seattle-based biotech giant more than three… Read More
Life sciences employment and federal research funding have grown rapidly in the Seattle area since 2019, according to a new report from real estate firm CBRE. The Seattle area ranked… Read More
When Eric Nealy returned from a workshop with other Black scientists, his perspective changed. The experience gave him a new — and unfamiliar — sense of belonging. “I was blown away,” said… Read More
Peter Lee has spent a lot of time recently with GPT-4, the AI-powered tool that simulates human conversation, built by OpenAI with contributions from its partner Microsoft. “I lost a… Read More
The news: Sonoma Biotherapeutics is partnering with Regeneron to co-develop cell therapies for Crohn’s disease and other autoimmune conditions. The agreement comes with a $75 million upfront payment and a… Read More
Clay Siegall is proud of his legacy as co-founder and longtime CEO of Seagen, the largest biotech company in the Seattle area. “I built a great company,” Siegall said in… Read More
Seagen founder Clay Siegall is jumping back into the biotech world as CEO and president of Morphimmune. Founded in 2020, the Purdue University spinout will relocate its headquarters to the… Read More
Microsoft-owned AI company Nuance is leveraging GPT-4 to power new software designed to ease the burden of clinical documentation for physicians. Nuance, acquired last year by Microsoft for $19.7 billion,… Read More
Seattle-area biotech experts are eying the past warily in the wake of this week’s news that Pfizer plans to acquire Bothell, Wash.-based Seagen for a whopping $43 billion. Most previous… Read More
— Rebecca Lovell was named chief operating officer of Greater Seattle Partners, a public-private sector initiative that seeks to attract investment, companies and quality jobs in the Seattle area. Lovell… Read More
Biopharma acquisitions often come with layoffs and lab shutdowns as smaller companies get absorbed. Whether that happens to Seagen is a big question that will impact the Seattle-area biotech community.… Read More
Pfizer is buying Seattle-area biotech giant Seagen in a massive $43 billion deal announced Monday. The deal is the largest biopharma transaction in three years, and comes after reports emerged… Read More
Cambridge, Mass.-based biotech company Moderna is opening an office in Seattle to build up its tech capacity, the company announced Friday morning. The office will focus on artificial intelligence, cloud-based… Read More
Neoleukin Therapeutics is slashing its workforce by about 70% as it seeks “strategic alternatives” for its future, according to a company statement Wednesday. The publicly traded Seattle biotech company hired… Read More
The news: Seattle-area healthcare startup Aiberry raised $8 million for its AI-powered software that analyzes audio, visual, and language from a short conversation to screen for mental health conditions. How… Read More
Seattle and Philadelphia area-based primary healthcare company Accolade is cutting its workforce and closing or reducing some facilities, according to a recent regulatory filing. A company spokesperson declined to say… Read More
Healthcare company 98point6 is selling a portion of its business to San Francisco-based startup Transcarent for $100 million in cash and equity. The deal will include the virtual care platform… Read More
University of Washington students developing a potential test for endometriosis took home the top prize Thursday at the 8th annual UW Hollomon Health Innovation Challenge. The competition gives students the… Read More
Danish multinational biopharma company Novo Nordisk is laying off 86 employees in Seattle, according to a new filing with the Washington state Employment Security Department. A spokesperson confirmed the cuts… Read More
There’s a new institute brewing at the University of Washington at the intersection of artificial intelligence, machine learning and healthcare. The Institute for Medical Data Science launched publicly this week… Read More
A new startup born out of Pioneer Square Labs in Seattle wants to help independent workers — including those who don’t have medical insurance — save money at the pharmacy. Otis is… Read More
Biopharma giant Pfizer is eyeing an acquisition of Seagen, the biggest biotech company in the Seattle area, according to a report in the Wall Street Journal Monday. Talks between the companies are… Read More
Lawmakers in Washington state are considering legislation that would give a governor-appointed board extra authority to curtail the price of high-cost prescription medications. Proponents say the legislation will increase access… Read More
